WHO to endorse GLP-1 drugs for obesity, calls for global access The World Health Organization is poised to officially endorse GLP-1 medications like Wegovy and Zepbound for treating obesity in adults worldwide by August or September 2025
Found naturally in the body, glutathione levels can decline with age, stress, poor diet, and exposure to environmental toxins, making supplementation a popular choice for those seeking to improve health, longevity, and vitality
This result suggests that semaglutide has cardioprotective effect independent of any substantial glucose lowering properties
Recovery Support Helps replenish fluids and nutrients after stress, travel, or fatigue.
baumannii (MRAB) isolates were sensitive only to amikacin
This medication has gained attention for its effectiveness in helping patients achieve their weight loss goals